Europe Hypodermics Market Size, Share & Trends Analysis Report By Product (Hypodermic Needles, Hypodermic Syringes), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Type
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources & Third-Party Perspectives
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increase in number of needlestick injuries
    • 3.2.1.2. Rising vaccination rates and campaigns
    • 3.2.1.3. Advancements in hypodermic syringes and needles
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recalls and field safety notices
    • 3.2.2.2. Adverse effects associated with hypodermic needles
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. Product Type Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Europe Hypodermic Syringes and Needles Market: Product Type Movement Analysis
• 4.3. Europe Hypodermic Syringes and Needles Market Size & Trend Analysis, by Product Type, 2018 - 2030 (USD Million)
• 4.4. Hypodermic Syringes
  • 4.4.1. Hypodermic Syringes Market, 2018 - 2030 (USD Million)
  • 4.4.2. Conventional Syringes
    • 4.4.2.1. Conventional Syringes Market, 2018 - 2030 (USD Million)
  • 4.4.3. Safety Syringes
    • 4.4.3.1. Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.4.3.2. Retractable Safety Syringes
      • 4.4.3.2.1. Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.4.3.3. Non-retractable Safety Syringes
      • 4.4.3.3.1. Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
• 4.5. Hypodermic Needles
  • 4.5.1. Hypodermic Needles Market, 2018 - 2030 (USD Million)
  • 4.5.2. Conventional Needles
    • 4.5.2.1. Conventional Needles Market, 2018 - 2030 (USD Million)
  • 4.5.3. Safety Needles
    • 4.5.3.1. Safety Needles Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

• 5.1. End Use Segment Dashboard
• 5.2. Europe Hypodermic Syringes and Needles Market: End-use Movement Analysis
• 5.3. Europe Hypodermic Syringes and Needles Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.5. Clinics
  • 5.5.1. Clinics Market, 2018 - 2030 (USD Million)
• 5.6. Ambulatory Surgical Centers
  • 5.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
• 5.7. Veterinary
  • 5.7.1. Veterinary Market, 2018 - 2030 (USD Million)
• 5.8. Home Care
  • 5.8.1. Home Care Market, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Europe Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis by Product Type, End Use

• 6.1. Regional Dashboard
• 6.2. Market Size and Trend Analysis, 2018 to 2030
• 6.3. Europe
  • 6.3.1. Europe hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. U.K.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Competitive scenario
    • 6.3.2.3. Regulatory framework
    • 6.3.2.4. Reimbursement scenario
    • 6.3.2.5. U.K. hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Ireland
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Competitive scenario
    • 6.3.3.3. Regulatory framework
    • 6.3.3.4. Reimbursement scenario
    • 6.3.3.5. Ireland hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Denmark
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Competitive scenario
    • 6.3.4.3. Regulatory framework
    • 6.3.4.4. Reimbursement scenario
    • 6.3.4.5. Denmark hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Finland
    • 6.3.5.1. Key country dynamics
    • 6.3.5.2. Competitive scenario
    • 6.3.5.3. Regulatory framework
    • 6.3.5.4. Reimbursement scenario
    • 6.3.5.5. Finland hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Iceland
    • 6.3.6.1. Key country dynamics
    • 6.3.6.2. Competitive scenario
    • 6.3.6.3. Regulatory framework
    • 6.3.6.4. Reimbursement scenario
    • 6.3.6.5. Iceland hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Norway
    • 6.3.7.1. Key country dynamics
    • 6.3.7.2. Competitive scenario
    • 6.3.7.3. Regulatory framework
    • 6.3.7.4. Reimbursement scenario
    • 6.3.7.5. Norway hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key country dynamics
    • 6.3.8.2. Competitive scenario
    • 6.3.8.3. Regulatory framework
    • 6.3.8.4. Reimbursement scenario
    • 6.3.8.5. Sweden hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Position Analysis
• 7.3. Strategy Mapping
• 7.4. Company Profiles/Listing
  • 7.4.1. BD (Becton, Dickinson & Corporation)
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Service Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Cardinal Health
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Service Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. B. Braun SE
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Service Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. ICU Medical
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Service Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Terumo Corporation
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Service Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Nipro Europe Group Companies (Nipro Corporation)
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Service Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. SolM
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Service Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. GBUK Group Ltd.
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Service Benchmarking
    • 7.4.8.4. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Europe hypodermics market revenue estimates and forecast, by product, 2018 - 2030 (USD Million)
• Table 4 Europe hypodermics market revenue estimates and forecast, by end-use, 2018 - 2030 (USD Million)
• Table 5 Key companies/organizations

List of Figures

• Fig. 1 Europe hypodermics market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Value chain based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Market snapshot (regional)
• Fig. 8 Product and end use segment snapshot
• Fig. 9 Competitive landscape snapshot
• Fig. 10 Market dynamics
• Fig. 1 Breakdown of needlestick injury claims reported to NHS 2012 - 2022
• Fig. 2 COVID-19 and flu vaccinations of frontline healthcare workers in the NHS Electronic Staff Record (ESR) in England from September 11, 2023, to January 24, 2024
• Fig. 3 Pharma drug pipelines for a few European countries as of December 2022
• Fig. 4 Porter's five forces analysis
• Fig. 5 PESTLE analysis
• Fig. 6 Hypodermics market: Product outlook and key takeaways
• Fig. 7 Hypodermics market: Product movement analysis
• Fig. 8 Diabetes estimates (20 - 79 y) in thousand
• Fig. 9 Hypodermic needles market estimates and forecast, 2018 - 2030 USD Million
• Fig. 10 Hypodermic syringes market estimates and forecast, 2018 - 2030 USD Million
• Fig. 11 Hypodermics market: End use outlook and key takeaways
• Fig. 12 Hypodermics market: End Use movement analysis
• Fig. 13 Hospitals market estimates and forecast, 2018 - 2030 USD Million
• Fig. 14 Clinics market estimates and forecast, 2018 - 2030 USD Million
• Fig. 15 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 USD Million
• Fig. 16 Veterinary market estimates and forecast, 2018 - 2030 USD Million
• Fig. 17 Home care market estimates and forecast, 2018 - 2030 USD Million
• Fig. 18 Others market estimates and forecast, 2018 - 2030 USD Million
• Fig. 19 Hypodermics market revenue by country, 2023 & 2030 (USD Million)
• Fig. 20 Key country dynamics
• Fig. 21 UK hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Key country dynamics
• Fig. 23 Ireland hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Key country dynamics
• Fig. 25 Denmark hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Key country dynamics
• Fig. 27 Finland hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Key country dynamics
• Fig. 29 Iceland hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Key country dynamics
• Fig. 31 Norway hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Key country dynamics
• Fig. 33 Sweden hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Key company categorization
• Fig. 35 Company share analysis (%)